News

Healthcare and research should pass useful information back and forth whenever possible.

PHACT is making inroads in drug development for neglected disease.

The EFGCP has organized a meeting next month in Trondheim, Norway, that will focus specifically on complex cases.

ERT and UCLA partner in postmarket studies with an eye toward telehealth.

A new service is launching at the end of the month that should help make recruitment easier.

A quantitative approach to enhancing risk assessment and mitigation in drug development.

Allison Burmeister discussed the average cost increase based on the per patient cost in a clinical trial during her presentation at the ExL Pharma C.R.O.W.N. Event.

TTC

There's a rapidly growing trend towards targeted (or risk-based) site monitoring and data review. However, some organizations remain concerned about the potential impact on data quality.

The benefits to virtual trials seem endless.

DIA Exhibitor Profiles 2012